235 related articles for article (PubMed ID: 1358031)
21. [Genetic alterations of human colorectal cancer].
Suzuki T; Ishioka C; Gamo M; Niitani T; Shimodaira H; Kanbe M; Yamazaki T; Yusa Y; Kanamaru R
Gan To Kagaku Ryoho; 1994 Feb; 21(3):343-50. PubMed ID: 8109990
[TBL] [Abstract][Full Text] [Related]
22. [Molecular genetics of ovarian cancer].
Yanaihara N; Okamoto A; Takakura S; Yamada K; Ochiai K; Tanaka T
Nihon Rinsho; 2004 Oct; 62 Suppl 10():441-8. PubMed ID: 15535284
[No Abstract] [Full Text] [Related]
23. [Metastasis related genes and malignancy in human esophageal, gastric and colorectal cancers].
Tahara E; Kuniyasu H; Nakayama H; Yasui W; Yokozaki H
Gan To Kagaku Ryoho; 1993 Feb; 20(3):326-31. PubMed ID: 8094950
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
25. [Molecular analysis of breast cancers: recent developments].
Bièche I; Lidereau R
Bull Cancer; 1992; 79(12):1115-33. PubMed ID: 1304832
[TBL] [Abstract][Full Text] [Related]
26. Multistep carcinogenesis in colorectal cancers.
Takami K; Yana I; Kurahashi H; Nishisho I
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():190-6. PubMed ID: 8629105
[TBL] [Abstract][Full Text] [Related]
27. Alterations of tumor suppressor genes in bladder cancer.
Cordon-Cardo C; Reuter VE
Semin Diagn Pathol; 1997 May; 14(2):123-32. PubMed ID: 9179973
[TBL] [Abstract][Full Text] [Related]
28. Concurrent abnormal expression of erbB-2, myc and ras genes is associated with poor outcome of ovarian cancer patients.
Katsaros D; Theillet C; Zola P; Louason G; Sanfilippo B; Isaia E; Arisio R; Giardina G; Sismondi P
Anticancer Res; 1995; 15(4):1501-10. PubMed ID: 7654038
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
30. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].
Bréchot JM; Molina T; Theobald S; Depierre A; Lagrange JL; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Lemarié E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stcebner-Delbarre A;
Bull Cancer; 2002 Oct; 89(10):857-67. PubMed ID: 12441277
[TBL] [Abstract][Full Text] [Related]
31. [Recent developments in the molecular genetic understanding of ovarian carcinoma].
Shimizu Y
Nihon Rinsho; 2004 Oct; 62 Suppl 10():489-95. PubMed ID: 15535294
[No Abstract] [Full Text] [Related]
32. Genetic basis of cancer of the pancreas: diagnostic and therapeutic applications.
Sakorafas GH; Tsiotou AG
Eur J Surg; 1994 Oct; 160(10):529-34. PubMed ID: 7849153
[TBL] [Abstract][Full Text] [Related]
33. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
Smith CA; Pollice AA; Gu LP; Brown KA; Singh SG; Janocko LE; Johnson R; Julian T; Hyams D; Wolmark N; Sweeney L; Silverman JF; Shackney SE
Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
[TBL] [Abstract][Full Text] [Related]
34. Amplifications of proto-oncogenes in ovarian carcinoma.
Bian M; Fan Q; Huang S; Ma J; Lang J
Chin Med J (Engl); 1995 Nov; 108(11):844-8. PubMed ID: 8585978
[TBL] [Abstract][Full Text] [Related]
35. Oncogenes and suppressor genes: their involvement in colon cancer.
Rigas B
J Clin Gastroenterol; 1990 Oct; 12(5):494-9. PubMed ID: 2229991
[TBL] [Abstract][Full Text] [Related]
36. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
[TBL] [Abstract][Full Text] [Related]
37. Genetic alterations in mouse lung tumors: implications for cancer chemoprevention.
Herzog CR; Lubet RA; You M
J Cell Biochem Suppl; 1997; 28-29():49-63. PubMed ID: 9589349
[TBL] [Abstract][Full Text] [Related]
38. Amplification of the C-erbB-2(HER-2/neu) proto-oncogene in ovarian carcinomas.
Fan QB; Bian ML; Huang SZ; Lang JH; Ma J; Liu WS; Xu XY
Chin Med J (Engl); 1994 Aug; 107(8):589-93. PubMed ID: 7805442
[TBL] [Abstract][Full Text] [Related]
39. A genetic basis for the multi-step pathway of colorectal tumorigenesis.
Fearon ER
Princess Takamatsu Symp; 1991; 22():37-48. PubMed ID: 1668892
[TBL] [Abstract][Full Text] [Related]
40. K-ras codon 12 mutation determines the polypoid growth of colorectral cancer.
Chiang JM; Chou YH; Chou TB
Cancer Res; 1998 Aug; 58(15):3289-93. PubMed ID: 9699657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
